Imprimis Pharmaceuticals Inc., of Solana Beach, Calif., added Lee S. Simon and Allan Green to its science and regulatory advisory board...Islet Sciences Inc., of New York, added Kevan Herold and Morton Printz to its scientific advisory board

Eli Lilly and Co., of Indianapolis, named Michael Harrington senior vice president and general counsel...Vertex Pharmaceuticals Inc., of Cambridge, Mass., appointed Stuart Arbuckle executive vice president and chief commercial officer

Actinium Pharmaceuticals Inc., of New York, hired Jack V. Talley as president and CEO and added Enza Guagenti as chief financial officer...BioMotiv LLC, of Cleveland, named Baiju R. Shah CEO and board member, effective Sept...ImmunoCellular Therapeutics Ltd., of Los Angeles, named John S. Yu interim CEO and president

he will chair the audit committee and serve on the compensation committee...Dynavax Technologies Corp., of Berkeley, Calif., named Christine Larson vice president and chief financial officer...Nile Therapeutics Inc., of San Mateo, Calif., named Darlene Horton president and CEO, and director

Mark Oki senior vice president, finance and chief financial officer...Shire plc, of Dublin, Ireland, appointed Soren Tulstrup senior vice president and franchise lead, MPS for its human genetic therapies business...Silence Therapeutics plc, of London, named Jerry Randall executive chairman and Ali Mortazavi director of corporate strategy

Caisson Biotech LLC, of Austin, Texas, appointed Glenn Nedwin CEO and president...Quanterix Corp., of Lexington, Mass., named Paul Chapman president and CEO...RXi Pharmaceuticals Corp., of Westborough, Mass., added Jeannette Graf and Leroy Young to its scientific advisory board

NovImmune SA, of Plan-Les-Ouates, Switzerland, added Michael Steinmetz to its board and appointed David Slack head of corporate and business development...Savient Pharmaceuticals Inc., of East Brunswick, N.J., appointed Louis Ferrari president and CEO...Xenetic Biosciences plc, of London, added Subash Kapre and Thomas Ulich to its scientific advisory board

Akshay Vaishnaw executive vice president and chief medical officer...and Thomas Rollins senior vice president of program and portfolio management

A.P. Pharma Inc., of Redwood City, Calif., added Barry Quart and Stephen Davis to it board...Saladax Biomedical Inc., of Bethlehem, Pa., named Kevin Harter president and CEO...Sequenom Inc., of San Diego, named Carolyn Beaver vice president and chief accounting officer

Gilead Sciences Inc., of Foster City, Calif., appointed Paul Boateng and Hannah Kettler to its health policy advisory board...Macrocure, of Petach Tikva, Israel, named Nissim Mashiach president and CEO...ViaCyte Inc., of San Diego, appointed Paul Laikind president and CEO

GenVec Inc., of Gaithersburg, Md., named Cynthia Collins president and CEO...Paratek Pharmaceuticals Inc., of Boston, appointed Dennis Molnar CEO and director and Evan Loh chief medical officer and board chairman

Generex Biotechnology Corp., of Worcester, Mass., added Keith Knutson and James Mule to its scientific advisory board...PolyTherics Ltd., of London, added Anker Lundemose and Nigel Pitchford to its board...Promedior Inc., of Malvern, Pa., appointed Suzanne Bruhn president and CEO

Tris Pharma Inc., of Monmouth Junction, N.J., named Amanda Wohlleber vice president of scale-up and technical services and Rajul Parikh vice president, operations...Vaximm AG, of Basel, Switzerland, and Mannheim, Germany, appointed Jean Paul Prieels to its board...Ziopharm Oncology Inc., of New York, appointed Jason Amello executive vice president and chief financial officer

Galena Biopharma Inc., of Lake Oswego, Ore., named Rosemary Mazanet executive vice president and chief medical officer and appointed Robert Figlin to its scientific advisory board...Incline Therapeutics Inc., of Redwood City, Calif, named John Tucker senior vice president and chief commercial officer

AMAG Pharmaceuticals Inc., of Lexington, Mass., appointed William Heiden president and CEO...Blueprint Medicines, of Cambridge, Mass., named George Demetri clinical advisor and member of the scientific advisory board...Cynapsus Therapeutics Inc., of Toronto, nominated Perry Molinoff, Thomas Picone and President and CEO Anthony Giovinazzo to its board

Biodel Inc., of Danbury, Conn., added Julia Brown and Davey Scoon to its board...Knopp Biosciences, of Pittsburgh, named Steven Boyd senior director of chemistry and Ian Reynolds senior director of biology...Sernova Corp., of London, Ontario, elected Bruce Weber and James Parsons to its board

XOMA Corp., of Berkeley, Calif., named Paul Rubin senior vice president, research and development

China Biologic Products Inc., of Beijing, added Zhijun Tong and Sandy (Han) Zhang to its board...Kolltan Pharmaceuticals Inc., of New Haven Conn., named Gerald McMahon president and CEO...Sorbent Therapeutics, of Sunnyvale, Calif., appointed Howard Dittrich chief medical officer and Randall Woods board chairman

and Santosh Varghese vice president of medical affairs...The company promoted Barbara Troupin to vice president, scientific communication and risk management...named CFO Timothy Morris senior vice president, global corporate development and finance